ETF Managers Group’s Vaxcyte PCVX Stock Holding History

ETF Managers Group’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$698K	Sell	18,630 -1,061	-5%	-$45K	0.02%	334
2022 Q4	$944K	Buy	19,691 +2,187	+12%	+$85.8K	0.04%	164
2022 Q3	$420K	Sell	17,504 -919	-5%	-$23.3K	0.01%	494
2022 Q2	$381K	Buy	18,423 +1,342	+8%	+$31.1K	0.01%	560
2022 Q1	$411K	Buy	17,081 +1,127	+7%	+$24.6K	0.01%	502
2021 Q4	$406K	Sell	15,954 -3,102	-16%	-$72.1K	0.01%	548
2021 Q3	$491K	Buy	19,056 +3,901	+26%	+$94.6K	0.01%	538
2021 Q2	$342K	Sell	15,155 -451	-3%	-$9.23K	0.01%	580
2021 Q1	$291K	Sell	15,606 -9,176	-37%	-$231K	0.01%	592
2020 Q4	$718K	Sell	24,782 -3,996	-14%	-$149K	0.02%	277
2020 Q3	$1.48M	Buy	+28,778	New	+$1.15M	0.05%	174

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ETF Managers Group's PCVX Position: Q1 2023 in Review

ETF Managers Group reduced its Vaxcyte (PCVX) stake by 5.4% in Q1 2023, selling an estimated $45K and leaving 18,630 shares worth $698K. The position accounts for 0.02% of the portfolio, ranked #334.

ETF Managers Group first reported a position in PCVX in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.48M in Q3 2020. 187 funds tracked by Wall St. Rank hold PCVX as of Q1 2023.

ETF Managers Group held 18,630 shares of Vaxcyte worth $698K as of Q1 2023.
ETF Managers Group sold 1,061 Vaxcyte shares in Q1 2023, an estimated $45K.
Vaxcyte made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #334 holding.
ETF Managers Group first reported a position in Vaxcyte in Q3 2020 and has held it in 11 quarters since.
ETF Managers Group's Vaxcyte position peaked at $1.48M in Q3 2020.
187 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.